Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
New ‘Cloud-9’ object could reveal the secrets of dark matter - 2Monetary Wellness: Planning Tips for Independence from the rat race
- 3‘Serving is not just a place’: Bayside Church Granite Bay reimagines annual mission amid conflict in Mexico
- 4SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- 5The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget
- NATO needs Ukraine's 'adaptation DNA' and an 'HOV lane' for new war tech, top commander says
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- 'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog
- Dozens of hidden star streams found in the outskirts of our Milky Way galaxy
- Pleasant Cycle Courses All over the Planet
- Self-sacrificing ants highlight the unity of their colony, say researchers
- Elvis Presley's Infamous Pantera Shooting
- Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market
- Council removes proposal to rename park named after former president of Israel
